Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that Proffesor Eddy Fan, an expert in critical care and extracorporeal life support methods, has joined Inspira Technologies’ Scientific Advisory Board.
Professor Eddy Fan is an associate professor in the Interdepartmental Division of Critical Care Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto and a staff intensivist at the University Health Network/Mount Sinai Hospital. Prof. Fan currently holds the medical director of the extracorporeal life support program at the Toronto General Hospital.
Prof. Eddy Fan, commented: “It is exciting to work with Inspira Technologies to design and develop novel extracorporeal support devices that will hopefully provide an additional tool for clinicians treating patients with acute respiratory failure and acute respiratory distress syndrome (ARDS).”
Dr. Fan received an undergraduate degree from the University of Toronto, his medical degree from the University of Western Ontario, and a doctorate in clinical investigation from Johns Hopkins University.
Prof. Fan’s area of academic focus is acute respiratory distress syndrome (ARDS), mechanical ventilation, and extracorporeal support. His research has focused on advanced life support for acute respiratory failure and patient outcomes after critical illness. These include investigations of the epidemiology and use of mechanical ventilation and extracorporeal life support in patients with ARDS, as well as on the development of ICU-acquired weakness, early rehabilitation in ICU patients, and long-term outcomes in survivors of critical illness.
Among his most significant publications:
- An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.” Intensive Care Medicine”
- Veno-venous extracorporeal membrane oxygenation for acute respiratory failure: a clinical review from an international group of experts.” JAMA”
- Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.
Dagi Ben-Noon, Inspira Technologies’ Chief Executive Officer, stated: “We are honored to have Professor Fan on Inspira Technologies’ Scientific Advisory Board. Professor Fan is a distinguished researcher, and his scientific expertise will be of great significance to Inspira Technologies in the development and potential deployment of its ART device.”